Roche announces FDA approval for COVID-19 test

2021 02 25 23 48 3444 Covid Virus Dna Molecule 400

Roche announced that the U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) for its Cobas SARS-CoV-2 nucleic acid test. The test is designed for use on the Cobas Liat system.

Through the authorization, symptomatic and asymptomatic individuals can be tested for COVID-19 at the point of care, with results made available within 20 minutes. The company said the polymerase chain reaction (PCR) test offers broad strain coverage of SARS-CoV-2 variants.

The test will be made available in July.

Page 1 of 22
Next Page